Pfizer Inc. and Eli Lilly and Company are pleased to announce the call for proposals for the 2nd Global Awards for Advancing Chronic Pain Research (ADVANCE) in 2019. ADVANCE is an independently-reviewed, competitive grants program. The mission of the program is to fund innovative, novel research proposals that seek to advance the understanding and management of chronic pain.
Proposals will be reviewed by an external, Independent Review Committee comprising renowned, global experts in chronic pain and will be reviewed based on area of interest, originality, scientific merit, and feasibility. The program will fund approximately 5 individual research proposals between US $50,000 and US $200,000 for a total of US $1 million.
For further information, please visit advanceresearchawards-chronicpain.com, or email the ADVANCE program coordinator at ADVANCEqueries@EnvisionPharmaGroup.com with any questions.
Application deadline: August 8, 2019